Status:

COMPLETED

Zinc for the Treatment of Herpes Simplex Labialis (HSL)

Lead Sponsor:

Integrative Medicine Institute

Collaborating Sponsors:

Women's Health Services, Santa Fe, New Mexico

Southwest College of Naturopathic Medicine

Conditions:

Herpes Simplex Labialis

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

Evaluate the effectiveness of a topical preparation of zinc to treat cold sores.

Detailed Description

Zinc salts irreversibly inhibit herpes virus replication in vitro and are effective in treating herpes infections in vivo and have been shown in a clinical trial to be a effective topical treatment fo...

Eligibility Criteria

Inclusion

  • Subjects with a history of HSL with at least 2 episodes/year for the past two years that have proceeded beyond the prodromal (initial) stage
  • Male or female subjects between 18 and 65 years of age
  • Symptoms or signs of HSL for less than one day (max. 36 hours from onset of symptoms to first visit)
  • Confirmation of HSL by a clinician at the study site
  • Willing to comply with study instructions and sign an informed consent

Exclusion

  • HSL symptoms or signs for more than one day
  • Cold sore outbreak within the past 2 weeks
  • Previous participation in this clinical trial
  • Topical or oral antiviral drug use in the past 1 week
  • Immune deficiency (HIV positive), chronic steroid therapy, present anti-neoplastic or radiation therapy, Hodgkin's disease, splenectomy, leukemia, myeloma, lymphoma, or another condition/drug per judgment of attending health care professional) or currently taking immune suppressive drugs. Previous organ or bone marrow transplant.
  • Pregnancy or lactation
  • Unable to travel to the clinic area for the required visits
  • Apparent inability to understand or follow the instructions associated with the clinical study
  • History of adverse events to the study material or facial cosmetics

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

157 Patients enrolled

Trial Details

Trial ID

NCT00809809

Start Date

December 1 2008

End Date

December 1 2010

Last Update

January 8 2014

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Steven Messer ND, DHANP

Tempe, Arizona, United States, 85282

2

Deborah Thompson, MD MSPH

Santa Fe, New Mexico, United States, 87501

3

Benjamin Kligler, MD

New York, New York, United States, 10016